This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2010.
Company Filing History:
1 out of 834,307 Years Active: 2010
Title: Michael P Manns: Innovator in Hepatitis B Treatment
Introduction
Michael P Manns is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical science, particularly in the treatment of viral infections. His innovative approach focuses on inhibiting the synthesis of viral DNA in mammals infected with the hepatitis B virus.
Latest Patents
Michael P Manns holds 1 patent related to a method of inhibiting the synthesis of viral DNA in mammals infected with the hepatitis B virus. This patent outlines a method that includes administering at least one component or substance to a mammal infected with the virus. The method aims to inhibit hepatitis B viral DNA synthesis and expression of at least one hepatitis B viral gene, potentially forming part of a strategy to prevent or treat hepatitis B infection.
Career Highlights
Throughout his career, Michael P Manns has focused on innovative solutions to combat viral infections. His work has been instrumental in advancing the understanding and treatment of hepatitis B, contributing to improved health outcomes for affected individuals.
Collaborations
Michael P Manns has collaborated with various professionals in the field, including his coworker, Michael Ott. These collaborations have fostered a productive environment for research and innovation.
Conclusion
Michael P Manns is a dedicated inventor whose work in hepatitis B treatment showcases the importance of innovation in medical science. His contributions continue to pave the way for advancements in the fight against viral infections.